Added Prognostic Value of Visually Estimated Coronary Artery Calcium Among Heart Transplant Recipients

作者：K. Clerkin, L. Sewanan, Jan M. Griffin, E. Defilippis, Boyu Peng, M. Chernovolenko, Erin Harris, N. Prasad, P. Colombo, M. Yuzefpolskaya, Justin A. Fried, J. Raikhelkar, V. Topkara, M.R. Castillo, Elaine Y. Lam, F. Latif, Koji Takeda, N. Uriel, G. Sayer, A. J. Einstein · 发表于：The Journal of Heart and Lung Transplantation · 年份：2024 · DOI：10.1016/j.healun.2024.07.024 · 被引用次数：7 · 研究领域：Medicine

Background: Cardiac hybrid positron emission tomography/computed tomography (PET/CT) has become a valid screening modality for cardiac allograft vasculopathy (CAV) following HT. Visually estimated coronary artery calcium (VECAC) can be quantified from CT images obtained as part of PET/CT and has been shown to be associated with adverse cardiovascular outcomes in coronary artery disease. We investigated the prognostic value of VECAC following heart transplantation (HT). Methods: A retrospective analysis of 430 consecutive adult HT patients who underwent 13N-ammonia cardiac PET/CT from 2016–2019 with follow-up through October 15, 2022, was performed. VECAC categories included: VECAC 0, VECAC 1–9, VECAC 10–99, and VECAC 100+. The association between VECAC categories and outcomes was assessed using univariable and multivariable proportional hazards regression. The primary outcome was death/retransplantation. Results: The cohort was 73% male, 33% had diabetes, 67% had estimated glomerular filtration rate<60 mL/min, median age was 61 years, and median time since HT was 7.5 years. VECAC alone was insufficiently sensitive to screen for CAV. During a median follow-up of 4.2 years ninety patients experienced death or retransplantation. Compared with those with VECAC 0, patients VECAC 10–99 (HR 2.25, 95% CI 1.23–4.14, p=0.009) and VECAC 100+ (HR 3.42, 95% CI 1.96–5.99, p<0.001) experienced an increased risk of death/retransplantation. The association was similar for cardiovascular death...